UK markets closed

ACADIA Pharmaceuticals Inc. (ACAD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
15.15-0.61 (-3.87%)
As of 02:09PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 2.55B
Enterprise value 2.18B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.99
Price/book (mrq)6.00
Enterprise value/revenue 4.26
Enterprise value/EBITDA -9.90

Trading information

Stock price history

Beta (5Y monthly) 0.60
52-week change 3-18.76%
S&P500 52-week change 3-11.32%
52-week high 328.06
52-week low 312.24
50-day moving average 315.85
200-day moving average 318.18

Share statistics

Avg vol (3-month) 31.42M
Avg vol (10-day) 3844.12k
Shares outstanding 5161.93M
Implied shares outstanding 6N/A
Float 8119.59M
% held by insiders 10.14%
% held by institutions 194.80%
Shares short (14 Nov 2022) 49.04M
Short ratio (14 Nov 2022) 45.82
Short % of float (14 Nov 2022) 47.55%
Short % of shares outstanding (14 Nov 2022) 45.58%
Shares short (prior month 13 Oct 2022) 49.52M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin -42.49%
Operating margin (ttm)-43.44%

Management effectiveness

Return on assets (ttm)-21.04%
Return on equity (ttm)-43.79%

Income statement

Revenue (ttm)511.5M
Revenue per share (ttm)3.16
Quarterly revenue growth (yoy)-0.70%
Gross profit (ttm)225.59M
EBITDA -220.12M
Net income avi to common (ttm)-217.34M
Diluted EPS (ttm)-1.33
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)436.58M
Total cash per share (mrq)2.7
Total debt (mrq)63M
Total debt/equity (mrq)14.80
Current ratio (mrq)4.47
Book value per share (mrq)2.63

Cash flow statement

Operating cash flow (ttm)-113.3M
Levered free cash flow (ttm)-27.21M